{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:10:41Z","timestamp":1792797041069,"version":"4.5.0"},"reference-count":178,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Metabolic dysfunction-associated steatotic liver disease (MASLD) affects over 30% of adults globally, yet therapeutic options remain limited. Macrophage metabolic reprogramming is increasingly recognized as an important contributor to disease progression. Hepatic macrophages from resident Kupffer cells (KCs) to infiltrating monocyte-derived macrophages (MoMFs) and triggering receptor expressed on myeloid cells 2 (TREM2)\n                    <jats:sup>+<\/jats:sup>\n                    lipid-associated macrophages (LAMs) shift their bioenergetic profile from fatty acid oxidation (FAO) and oxidative phosphorylation (OXPHOS) toward aerobic glycolysis. This review maps the metabolic circuits driving macrophage-mediated inflammation in MASLD. We delineate how tricarboxylic acid (TCA) cycle disruption generates signaling metabolites that enforce glycolytic commitment through hypoxia-inducible factor stabilization, how metabolic-epigenetic coupling perpetuates inflammatory programs, and how the failure of repair mechanisms and mitochondrial quality control accelerates tissue damage. Notably, the IRG1-itaconate axis exhibits a dynamic U-shaped trajectory across MASLD stages: itaconate levels decrease during early steatosis due to Kupffer cell loss, but subsequently rise markedly during MASH as infiltrating macrophages upregulate IRG1 expression, representing a compensatory yet insufficient anti-inflammatory response. We further examine how these metabolic states evolve across disease stages, from simple steatosis through steatohepatitis and fibrosis to cirrhosis, and assess the therapeutic potential of metabolic interventions. Recent FDA accelerated approvals of resmetirom and semaglutide for selected adults with non-cirrhotic MASH and F2-F3 fibrosis have expanded the therapeutic landscape. Their clinical benefits are primarily supported by histological endpoints; whether modulation of hepatic macrophage metabolism contributes directly to these benefits remains to be established. Emerging evidence indicates that macrophage metabolic states retain plasticity and can be pharmacologically reprogrammed, with single-cell metabolomics poised to guide precision therapeutic strategies.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1899587","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T08:55:28Z","timestamp":1786956928000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Revisiting macrophage metabolic reprogramming in metabolic dysfunction-associated steatotic liver disease: mechanisms, regulation, and therapeutic breakthroughs"],"prefix":"10.3389","volume":"17","author":[{"given":"Li","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Pathology, The First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, The First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-025-03895-6","article-title":"Global burden and risk factors of MASLD: trends from 1990 to 2021 and predictions to 2030","volume":"20","author":"Huang","year":"2025","journal-title":"Intern Emerg Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Younossi","year":"2025","journal-title":"Clin Mol Hepatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.02.026","article-title":"Targeting hepatic macrophages to treat liver diseases","volume":"66","author":"Tacke","year":"2017","journal-title":"J Hepatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.08.006","article-title":"A subset of Kupffer cells regulates metabolism through the expression of CD36","volume":"54","author":"Bl\u00e9riot","year":"2021","journal-title":"Immunity"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.11","article-title":"Liver macrophages in tissue homeostasis and disease","volume":"17","author":"Krenkel","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.70","article-title":"A guide to immunometabolism for immunologists","volume":"16","author":"O'Neill","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.it.2017.03.001","article-title":"Macrophage immunometabolism: Where are we (going)","volume":"38","author":"Van den Bossche","year":"2017","journal-title":"Trends Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/nature11986","article-title":"Succinate is an inflammatory signal that induces IL-1\u03b2 through HIF-1\u03b1","volume":"496","author":"Tannahill","year":"2013","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(03)00154-5","article-title":"HIF-1alpha is essential for myeloid cell-mediated inflammation","volume":"112","author":"Cramer","year":"2003","journal-title":"Cell"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1172\/JCI23865","article-title":"HIF-1alpha expression regulates the bactericidal capacity of phagocytes","volume":"115","author":"Peyssonnaux","year":"2005","journal-title":"J Clin Invest"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.08.064","article-title":"Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages","volume":"167","author":"Mills","year":"2016","journal-title":"Cell"},{"key":"B15","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41467-018-08187-6","article-title":"Malonylation of GAPDH is an inflammatory signal in macrophages","volume":"10","author":"Galv\u00e1n-Pe\u00f1a","year":"2019","journal-title":"Nat Commun"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2022","article-title":"Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling","volume":"12","author":"Wen","year":"2011","journal-title":"Nat Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1639455","article-title":"Macrophage heterogeneity in liver fibrosis","volume":"16","author":"Wang","year":"2025","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-025-02562-9","article-title":"The heterogeneity of monocyte-derived macrophages in MASH pathogenesis","volume":"24","author":"Zhang","year":"2025","journal-title":"Cell Commun Signal"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000001160","article-title":"Reprogramming macrophages to treat liver diseases","volume":"84","author":"Sim\u00f3n-Codina","year":"2026","journal-title":"Hepatology"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.708978","article-title":"Hepatic macrophage as a key player in fatty liver disease","volume":"12","author":"Xu","year":"2021","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1126\/science.1219179","article-title":"A lineage of myeloid cells independent of Myb and hematopoietic stem cells","volume":"336","author":"Schulz","year":"2012","journal-title":"Science"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/nature13989","article-title":"Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors","volume":"518","author":"Gomez Perdiguero","year":"2015","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10321","article-title":"Bone marrow-derived monocytes give rise to self-renewing and fully differentiated Kupffer cells","volume":"7","author":"Scott","year":"2016","journal-title":"Nat Commun"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.08.017","article-title":"Stellate cells, hepatocytes, and endothelial cells imprint the Kupffer cell identity on monocytes colonizing the liver macrophage niche","volume":"51","author":"Bonnardel","year":"2019","journal-title":"Immunity"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2022.08.002","article-title":"Liver macrophages in health and disease","volume":"55","author":"Guilliams","year":"2022","journal-title":"Immunity"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.107023","article-title":"Differential regulation of hepatic macrophage fate by Chi3l1 in MASLD","volume":"14","author":"He","year":"2026","journal-title":"ELife"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.12.025","article-title":"Macrophage heterogeneity in liver injury and fibrosis","volume":"60","author":"Tacke","year":"2014","journal-title":"J Hepatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1680878","article-title":"Macrophage-tregs crosstalk: the \u201chub\u201d of the immune network in MASLD","volume":"16","author":"Zhao","year":"2025","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11154358","article-title":"Macrophages, low-grade inflammation, insulin resistance and hyperinsulinemia: a mutual ambiguous relationship in the development of metabolic diseases","volume":"11","author":"P\u00fcschel","year":"2022","journal-title":"J Clin Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.06.003","article-title":"Impaired Kupffer cell self-renewal alters the liver response to lipid overload during non-alcoholic steatohepatitis","volume":"53","author":"Tran","year":"2020","journal-title":"Immunity"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.05.054","article-title":"Lipid-associated macrophages control metabolic homeostasis in a Trem2-dependent manner","volume":"178","author":"Jaitin","year":"2019","journal-title":"Cell"},{"key":"B32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.immuni.2022.12.011","article-title":"Eating macrophages for a healthy anti-NASH meal","volume":"56","author":"Lee","year":"2023","journal-title":"Immunity"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.08.004","article-title":"Osteopontin expression identifies a subset of recruited macrophages distinct from Kupffer cells in the fatty liver","volume":"53","author":"Remmerie","year":"2020","journal-title":"Immunity"},{"key":"B34","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.cell.2021.12.018","article-title":"Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches","volume":"185","author":"Guilliams","year":"2022","journal-title":"Cell"},{"key":"B35","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.immuni.2022.11.013","article-title":"Prolonged hypernutrition impairs TREM2-dependent efferocytosis to license chronic liver inflammation and NASH development","volume":"56","author":"Wang","year":"2023","journal-title":"Immunity"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1242\/bio.039420","article-title":"The role of NF-\u03baB and Elk-1 in the regulation of mouse ADAM17 expression","volume":"8","author":"Wawro","year":"2019","journal-title":"Biol Open"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2017.09.034","article-title":"ADAM17 is the main sheddase for the generation of human triggering receptor expressed in myeloid cells (hTREM2) ectodomain and cleaves TREM2 after Histidine 157","volume":"660","author":"Feuerbach","year":"2017","journal-title":"Neurosci Lett"},{"key":"B38","doi-asserted-by":"publisher","first-page":"243ra86","DOI":"10.1126\/scitranslmed.3009093","article-title":"TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis","volume":"6","author":"Kleinberger","year":"2014","journal-title":"Sci Transl Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02948","article-title":"The role of monocytes and macrophages in acute and acute-on-chronic liver failure","volume":"9","author":"Triantafyllou","year":"2018","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.4.2247","article-title":"Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury","volume":"275","author":"Friedman","year":"2000","journal-title":"J Biol Chem"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200524282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J Clin Invest"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1631-3","article-title":"Resolving the fibrotic niche of human liver cirrhosis at single-cell level","volume":"575","author":"Ramachandran","year":"2019","journal-title":"Nature"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2019.07.028","article-title":"Landscape of intercellular crosstalk in healthy and NASH liver revealed by single-cell secretome gene analysis","volume":"75","author":"Xiong","year":"2019","journal-title":"Mol Cell"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.add8945","article-title":"Identification of a broadly fibrogenic macrophage subset induced by type 3 inflammation","volume":"8","author":"Fabre","year":"2023","journal-title":"Sci Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/cells14020096","article-title":"Single-cell RNA sequencing reveals macrophage dynamics during MASH in leptin-deficient rats","volume":"14","author":"Xin","year":"2025","journal-title":"Cells"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108626","article-title":"Dynamic shifts in the composition of resident and recruited macrophages influence tissue remodeling in NASH","volume":"34","author":"Daemen","year":"2021","journal-title":"Cell Rep"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2024.08.010","article-title":"Myeloid beta-arrestin 2 depletion attenuates metabolic dysfunction-associated steatohepatitis via the metabolic reprogramming of macrophages","volume":"36","author":"Wei","year":"2024","journal-title":"Cell Metab"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.06.004","article-title":"Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation","volume":"24","author":"Lampropoulou","year":"2016","journal-title":"Cell Metab"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1126\/science.1164097","article-title":"ATP-citrate lyase links cellular metabolism to histone acetylation","volume":"324","author":"Wellen","year":"2009","journal-title":"Science"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.11.020","article-title":"Acetate dependence of tumors","volume":"159","author":"Comerford","year":"2014","journal-title":"Cell"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/nature10602","article-title":"Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia","volume":"481","author":"Metallo","year":"2011","journal-title":"Nature"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adf0115","article-title":"Acetylcarnitine shuttling links mitochondrial metabolism to histone acetylation and lipogenesis","volume":"9","author":"Izzo","year":"2023","journal-title":"Sci Adv"},{"key":"B53","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41467-019-13668-3","article-title":"Mitochondrial TCA cycle metabolites control physiology and disease","volume":"11","author":"Mart\u00ednez-Reyes","year":"2020","journal-title":"Nat Commun"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.676817","article-title":"Pro-inflammatory macrophages sustain pyruvate oxidation through pyruvate dehydrogenase for the synthesis of itaconate and to enable cytokine expression","volume":"291","author":"Meiser","year":"2016","journal-title":"J Biol Chem"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.02.032","article-title":"Cellular metabolism and disease: what do metabolic outliers teach us","volume":"148","author":"DeBerardinis","year":"2012","journal-title":"Cell"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1296687","article-title":"Pyruvate dehydrogenase kinase regulates macrophage polarization in metabolic and inflammatory diseases","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.685792","article-title":"Immunoresponsive gene 1 and itaconate inhibit succinate dehydrogenase to modulate intracellular succinate levels","volume":"291","author":"Cordes","year":"2016","journal-title":"J Biol Chem"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20160061","article-title":"GPR91 senses extracellular succinate released from inflammatory macrophages and exacerbates rheumatoid arthritis","volume":"213","author":"Littlewood-Evans","year":"2016","journal-title":"J Exp Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.molcel.2008.04.009","article-title":"Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway","volume":"30","author":"Kaelin","year":"2008","journal-title":"Mol Cell"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/nrm1366","article-title":"Oxygen sensing by HIF hydroxylases","volume":"5","author":"Schofield","year":"2004","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ccr.2004.11.022","article-title":"Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase","volume":"7","author":"Selak","year":"2005","journal-title":"Cancer Cell"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/nature09663","article-title":"A role for mitochondria in NLRP3 inflammasome activation","volume":"469","author":"Zhou","year":"2011","journal-title":"Nature"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M001914200","article-title":"Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing","volume":"275","author":"Chandel","year":"2000","journal-title":"J Biol Chem"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1793092","article-title":"Loss of immunometabolic adaptability in MASH: gut-derived signals drive macrophage reprogramming and fibrosis","volume":"17","author":"Li","year":"2026","journal-title":"Front Immunol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1186\/s12967-023-04431-w","article-title":"ACLY as a modulator of liver cell functions and its role in metabolic dysfunction-associated steatohepatitis","volume":"21","author":"Convertini","year":"2023","journal-title":"J Transl Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.428318","article-title":"Quantitative dynamics of the link between cellular metabolism and histone acetylation","volume":"288","author":"Evertts","year":"2013","journal-title":"J Biol Chem"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1126\/science.1056843","article-title":"Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2","volume":"291","author":"Abu-Elheiga","year":"2001","journal-title":"Science"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.11612","article-title":"Akt-mTORC1 signaling regulates Acly to integrate metabolic input to control of macrophage activation","volume":"5","author":"Covarrubias","year":"2016","journal-title":"Elife"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1021\/ja2070889","article-title":"Itaconic acid is a mammalian metabolite induced during macrophage activation","volume":"133","author":"Strelko","year":"2011","journal-title":"J Am Chem Soc"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1218599110","article-title":"Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production","volume":"110","author":"Michelucci","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-023-00801-2","article-title":"Itaconic acid underpins hepatocyte lipid metabolism in non-alcoholic fatty liver disease in male mice","volume":"5","author":"Weiss","year":"2023","journal-title":"Nat Metab"},{"key":"B72","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s00011-025-02087-4","article-title":"Reprogramming immunity with itaconate: metabolic mechanisms and therapeutic perspectives","volume":"74","author":"Gao","year":"2025","journal-title":"Inflammation Res"},{"key":"B73","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1096\/fj.15-279398","article-title":"Abolition of mitochondrial substrate-level phosphorylation by itaconic acid produced by LPS-induced Irg1 expression in cells of murine macrophage lineage","volume":"30","author":"N\u00e9meth","year":"2016","journal-title":"FASEB J"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0052-z","article-title":"Electrophilic properties of itaconate and derivatives regulate the I\u03baB\u03b6-ATF3 inflammatory axis","volume":"556","author":"Bambouskova","year":"2018","journal-title":"Nature"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2019.05.007","article-title":"The immunomodulatory potential of the metabolite itaconate","volume":"40","author":"Hooftman","year":"2019","journal-title":"Trends Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901698","article-title":"Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation","volume":"185","author":"Rodr\u00edguez-Prados","year":"2010","journal-title":"J Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/nri2607","article-title":"Interdependence of hypoxic and innate immune responses","volume":"9","author":"Nizet","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25497","article-title":"Hypoxia and hypoxia inducible factors: diverse roles in liver diseases","volume":"55","author":"Nath","year":"2012","journal-title":"Hepatology"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-0674(00)00194-0","article-title":"HIF-1 and mechanisms of hypoxia sensing","volume":"13","author":"Semenza","year":"2001","journal-title":"Curr Opin Cell Biol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.21.10.3436-3444.2001","article-title":"Transcription factor HIF-1 is a necessary mediator of the pasteur effect in mammalian cells","volume":"21","author":"Seagroves","year":"2001","journal-title":"Mol Cell Biol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2006.02.002","article-title":"HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia","volume":"3","author":"Kim","year":"2006","journal-title":"Cell Metab"},{"key":"B82","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1084\/jem.20151570","article-title":"Immunometabolism governs dendritic cell and macrophage function","volume":"213","author":"O'Neill","year":"2016","journal-title":"J Exp Med"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2012.04.023","article-title":"The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism","volume":"15","author":"Haschemi","year":"2012","journal-title":"Cell Metab"},{"key":"B84","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.molcel.2016.05.029","article-title":"Interplay between metabolism and epigenetics: a nuclear adaptation to environmental changes","volume":"62","author":"Etchegaray","year":"2016","journal-title":"Mol Cell"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2015.08.024","article-title":"Histone methylation dynamics and gene regulation occur through the sensing of one-carbon metabolism","volume":"22","author":"Mentch","year":"2015","journal-title":"Cell Metab"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2009778117","article-title":"TLR signaling adapter BCAP regulates inflammatory to reparatory macrophage transition by promoting histone lactylation","volume":"117","author":"Irizarry-Caro","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115350","article-title":"Hexokinase 2-mediated metabolic stress and inflammation burden of liver macrophages via histone lactylation in MASLD","volume":"44","author":"Li","year":"2025","journal-title":"Cell Rep"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22950","article-title":"Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis","volume":"50","author":"Karlmark","year":"2009","journal-title":"Hepatology"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2891-13-17","article-title":"Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications-a review","volume":"13","author":"Grygiel-G\u00f3rniak","year":"2014","journal-title":"Nutr J"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-310798","article-title":"Liver PPAR\u03b1 is crucial for whole-body fatty acid homeostasis and is protective against NAFLD","volume":"65","author":"Montagner","year":"2016","journal-title":"Gut"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M209649200","article-title":"Scavenger receptors class A-I\/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages","volume":"277","author":"Kunjathoor","year":"2002","journal-title":"J Biol Chem"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1172\/JCI28898","article-title":"TLR4 links innate immunity and fatty acid-induced insulin resistance","volume":"116","author":"Shi","year":"2006","journal-title":"J Clin Invest"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1210\/en.2005-1132","article-title":"Peroxisome proliferator-activated receptor alpha mediates the effects of high-fat diet on hepatic gene expression","volume":"147","author":"Patsouris","year":"2006","journal-title":"Endocrinology"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-018-0082-x","article-title":"The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"16","author":"Kazankov","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1126\/science.1103160","article-title":"Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes","volume":"306","author":"Ozcan","year":"2004","journal-title":"Science"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20081386","article-title":"How mitochondria produce reactive oxygen species","volume":"417","author":"Murphy","year":"2009","journal-title":"Biochem J"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2012.09.025","article-title":"Physiological roles of mitochondrial reactive oxygen species","volume":"48","author":"Sena","year":"2012","journal-title":"Mol Cell"},{"key":"B99","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.cell.2015.12.057","article-title":"NF-\u03baB restricts inflammasome activation via elimination of damaged mitochondria","volume":"164","author":"Zhong","year":"2016","journal-title":"Cell"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-018-0176-2","article-title":"Mechanisms of mitophagy in cellular homeostasis, physiology and pathology","volume":"20","author":"Palikaras","year":"2018","journal-title":"Nat Cell Biol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2010.09.019","article-title":"Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network","volume":"1813","author":"Scarpulla","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3013","article-title":"Mitochondrial fusion and fission in cell life and death","volume":"11","author":"Westermann","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.cmet.2018.06.001","article-title":"Etomoxir inhibits macrophage polarization by disrupting CoA homeostasis","volume":"28","author":"Divakaruni","year":"2018","journal-title":"Cell Metab"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2014.02.002","article-title":"Integrated physiology and systems biology of PPAR\u03b1","volume":"3","author":"Kersten","year":"2014","journal-title":"Mol Metab"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1038\/nature06905","article-title":"NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha","volume":"453","author":"Rius","year":"2008","journal-title":"Nature"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/nri2873","article-title":"Sterile inflammation: sensing and reacting to damage","volume":"10","author":"Chen","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1126\/science.1219855","article-title":"Mitochondrial fission, fusion, and stress","volume":"337","author":"Youle","year":"2012","journal-title":"Science"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.09.016","article-title":"Metabolic reprogramming mediated by the mTORC2-IRF4 signaling axis is essential for macrophage alternative activation","volume":"45","author":"Huang","year":"2016","journal-title":"Immunity"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2018.1442436","article-title":"Cenicriviroc for the treatment of non-alcoholic steatohepatitis and liver fibrosis","volume":"27","author":"Tacke","year":"2018","journal-title":"Expert Opin Investig Drugs"},{"key":"B110","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cmet.2006.05.011","article-title":"Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation","volume":"4","author":"Vats","year":"2006","journal-title":"Cell Metab"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.12.7543","article-title":"Hypoxia-inducible factor 1-mediated inhibition of peroxisome proliferator-activated receptor alpha expression during hypoxia","volume":"166","author":"Narravula","year":"2001","journal-title":"J Immunol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.mam.2007.09.014","article-title":"Mitochondrial involvement in non-alcoholic steatohepatitis","volume":"29","author":"Serviddio","year":"2008","journal-title":"Mol Aspects Med"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2006.01.012","article-title":"HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption","volume":"3","author":"Papandreou","year":"2006","journal-title":"Cell Metab"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2026.1745201","article-title":"Hepatic mitochondrial signaling as a systemic hub: inter-organ communication networks in aging and aging-related diseases","volume":"14","author":"Ji","year":"2026","journal-title":"Front Cell Dev Biol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v17.i11.113756","article-title":"Roles of short-chain fatty acids in metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis","volume":"17","author":"Zhang","year":"2025","journal-title":"World J Hepatol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3390\/biom15040469","article-title":"The role of short-chain fatty acids in metabolic dysfunction-associated steatotic liver disease and other metabolic diseases","volume":"15","author":"M\u00fcnte","year":"2025","journal-title":"Biomolecules"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2025.00605","article-title":"The multifaceted roles of gut microbiota and their metabolites in metabolic dysfunction-associated steatotic liver disease: a literature review","volume":"14","author":"Zhang","year":"2026","journal-title":"J Clin Transl Hepatol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.609060","article-title":"TGR5 regulates macrophage inflammation in nonalcoholic steatohepatitis by modulating NLRP3 inflammasome activation","volume":"11","author":"Shi","year":"2020","journal-title":"Front Immunol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1693753","article-title":"Immunometabolic integration in therapeutic strategies for managing MASLD","volume":"16","author":"Gonz\u00e1lez-Serrano","year":"2025","journal-title":"Front Pharmacol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.immuni.2020.04.001","article-title":"Niche-specific reprogramming of epigenetic landscapes drives myeloid cell diversity in nonalcoholic steatohepatitis","volume":"52","author":"Seidman","year":"2020","journal-title":"Immunity"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.34133\/research.0382","article-title":"Metabolic dysfunction-associated steatohepatitis detected by neutrophilic crown-like structures in morbidly obese patients: a multicenter and clinicopathological study","volume":"7","author":"Fan","year":"2024","journal-title":"Res (Wash D C)"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2405746121","article-title":"Lipid-associated macrophages' promotion of fibrosis resolution during MASH regression requires TREM2","volume":"121","author":"Ganguly","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v17.i12.111153","article-title":"Histone lactylation: a key epigenetic modulator in the pathogenesis of metabolic dysfunction-associated steatohepatitis and alcoholic steatohepatitis","volume":"17","author":"Singh","year":"2025","journal-title":"World J Hepatol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000578","article-title":"Biological and clinical role of TREM2 in liver diseases","volume":"8","author":"Ma","year":"2024","journal-title":"Hepatol Commun"},{"key":"B125","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.matbio.2024.07.003","article-title":"Metabolic control of collagen synthesis","volume":"133","author":"Guillard","year":"2024","journal-title":"Matrix Biol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"S","DOI":"10.1016\/S0016-5085(25)04765-1","article-title":"Soluble TREM2 is a biomarker but not a mediator of fibrosing steatohepatitis","volume":"169","author":"Dempsey","year":"2025","journal-title":"Gastroenterology"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.107777","article-title":"The role of mitochondrial quality control in liver diseases: dawn of a therapeutic era","volume":"21","author":"Li","year":"2025","journal-title":"Int J Biol Sci"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2026.1743905","article-title":"Schisandra chinensis Fructus and its active metabolites for the treatment of metabolic dysfunction-associated steatotic liver disease","volume":"13","author":"Wang","year":"2026","journal-title":"Front Med (Lausanne)"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2017.00068","article-title":"Metabolic cooperation and competition in the tumor microenvironment: implications for therapy","volume":"7","author":"Gupta","year":"2017","journal-title":"Front Oncol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1039\/D5RA08026F","article-title":"Ferroptosis and immunity: rewiring the tumor microenvironment for therapy","volume":"16","author":"Ailun","year":"2026","journal-title":"RSC Adv"},{"key":"B131","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s13402-026-01183-9","article-title":"Hepatocellular carcinoma and vitamin D metabolism: novel targets and therapeutic strategies","volume":"49","author":"Gao","year":"2026","journal-title":"Cell Oncol (Dordr)"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2109","article-title":"Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils","volume":"12","author":"Galli","year":"2011","journal-title":"Nat Immunol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.1.342","article-title":"Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences","volume":"175","author":"Stout","year":"2005","journal-title":"J Immunol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","article-title":"The biology of cancer: metabolic reprogramming fuels cell growth and proliferation","volume":"7","author":"DeBerardinis","year":"2008","journal-title":"Cell Metab"},{"key":"B135","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/BF01116556","article-title":"The role of high rates of glycolysis and glutamine utilization in rapidly dividing cells","volume":"5","author":"Newsholme","year":"1985","journal-title":"Biosci Rep"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-04-217620","article-title":"Epigenetic regulation of the alternatively activated macrophage phenotype","volume":"114","author":"Ishii","year":"2009","journal-title":"Blood"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.03.011","article-title":"A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer","volume":"69","author":"Tsuchida","year":"2018","journal-title":"J Hepatol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1835489","article-title":"Targeting macrophages in liver fibrosis","volume":"17","author":"Gonz\u00e1lez Del Barrio","year":"2026","journal-title":"Front Immunol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2005.12.002","article-title":"From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions","volume":"45","author":"Feige","year":"2006","journal-title":"Prog Lipid Res"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1172\/JCI27989","article-title":"Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis","volume":"116","author":"Lefebvre","year":"2006","journal-title":"J Clin Invest"},{"key":"B141","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1053\/j.gastro.2016.01.038","article-title":"Elafibranor, an agonist of the peroxisome proliferator-activated receptor-\u03b1 and -\u03b4, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening","volume":"150","author":"Ratziu","year":"2016","journal-title":"Gastroenterology"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2036205","article-title":"A randomized, controlled trial of the pan-PPAR agonist lanifibranor in NASH","volume":"385","author":"Francque","year":"2021","journal-title":"N Engl J Med"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of PPAR\u03b1 action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"Pawlak","year":"2015","journal-title":"J Hepatol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1038\/nature05894","article-title":"Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance","volume":"447","author":"Odegaard","year":"2007","journal-title":"Nature"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-0093","article-title":"Effects of the new dual PPAR \u03b1\/\u03b4 agonist GFT505 on lipid and glucose homeostasis in abdominally obese patients with combined dyslipidemia or impaired glucose metabolism","volume":"34","author":"Cariou","year":"2011","journal-title":"Diabetes Care"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26461","article-title":"Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha\/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"58","author":"Staels","year":"2013","journal-title":"Hepatology"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg effect: how does it benefit cancer cells","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem Sci"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209603","article-title":"Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria","volume":"25","author":"Mathupala","year":"2006","journal-title":"Oncogene"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20101470","article-title":"Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme","volume":"208","author":"Wolf","year":"2011","journal-title":"J Exp Med"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1038\/nature06734","article-title":"The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth","volume":"452","author":"Christofk","year":"2008","journal-title":"Nature"},{"key":"B151","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cmet.2014.12.005","article-title":"Pyruvate kinase M2 regulates Hif-1\u03b1 activity and IL-1\u03b2 induction and is a critical determinant of the warburg effect in LPS-activated macrophages","volume":"21","author":"Palsson-McDermott","year":"2015","journal-title":"Cell Metab"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2006.04.023","article-title":"Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance","volume":"9","author":"Fantin","year":"2006","journal-title":"Cancer Cell"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0914433107","article-title":"Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression","volume":"107","author":"Le","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"B154","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cmet.2014.03.003","article-title":"Targeting lactate dehydrogenase--a inhibits tumorigenesis and tumor progression in mouse models of lung cancer and impacts tumor-initiating cells","volume":"19","author":"Xie","year":"2014","journal-title":"Cell Metab"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1038\/nature25986","article-title":"Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1","volume":"556","author":"Mills","year":"2018","journal-title":"Nature"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26783","article-title":"Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C(+) macrophage infiltration in mice","volume":"59","author":"Baeck","year":"2014","journal-title":"Hepatology"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29477","article-title":"A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis","volume":"67","author":"Friedman","year":"2018","journal-title":"Hepatology"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158156","article-title":"Antifibrotic effects of the dual CCR2\/CCR5 antagonist cenicriviroc in animal models of liver and kidney fibrosis","volume":"11","author":"Lefebvre","year":"2016","journal-title":"PloS One"},{"key":"B159","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.cgh.2023.04.003","article-title":"Cenicriviroc lacked efficacy to treat liver fibrosis in nonalcoholic steatohepatitis: AURORA Phase III randomized study","volume":"22","author":"Anstee","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"B161","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A Phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N Engl J Med"},{"key":"B162","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1056\/NEJMoa2401943","article-title":"Tirzepatide for metabolic dysfunction-associated steatohepatitis with liver fibrosis","volume":"391","author":"Loomba","year":"2024","journal-title":"N Engl J Med"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2401755","article-title":"A Phase 2 randomized trial of survodutide in MASH and fibrosis","volume":"391","author":"Sanyal","year":"2024","journal-title":"N Engl J Med"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.02.040","article-title":"Cell therapy for liver disease: From liver transplantation to cell factory","volume":"62","author":"Forbes","year":"2015","journal-title":"J Hepatol"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2017.05.009","article-title":"Development, functional characterization and validation of methodology for GMP-compliant manufacture of phagocytic macrophages: A novel cellular therapeutic for liver cirrhosis","volume":"19","author":"Fraser","year":"2017","journal-title":"Cytotherapy"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2024.101307","article-title":"Macrophage manufacturing and engineering with 5'-Cap1 and N1-methylpseudouridine-modified mRNA","volume":"32","author":"Zhang","year":"2024","journal-title":"Mol Ther Methods Clin Dev"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2024.12.002","article-title":"Smart cell therapy: an industry perspective on macrophages as living drugs","volume":"27","author":"Rodgers","year":"2025","journal-title":"Cytotherapy"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1093\/oxfimm\/iqae015","article-title":"Impact of cryopreservation on immune cell metabolism as measured by SCENITH","volume":"6","author":"Luscombe","year":"2025","journal-title":"Oxf Open Immunol"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.4110\/in.2023.23.e44","article-title":"Comparing the benefits and drawbacks of stem cell therapy based on the cell origin or manipulation process: Addressing immunogenicity","volume":"23","author":"Chang","year":"2023","journal-title":"Immune Netw"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-025-01422-3","article-title":"Generation of hypoimmunogenic universal iPS cells through HLA-type gene knockout","volume":"57","author":"Kim","year":"2025","journal-title":"Exp Mol Med"},{"key":"B171","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cell.2015.03.015","article-title":"Time for food: the intimate interplay between nutrition, metabolism, and the circadian clock","volume":"161","author":"Asher","year":"2015","journal-title":"Cell"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3599","article-title":"An epithelial circadian clock controls pulmonary inflammation and glucocorticoid action","volume":"20","author":"Gibbs","year":"2014","journal-title":"Nat Med"},{"key":"B173","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.cmet.2018.08.004","article-title":"Time-restricted feeding prevents obesity and metabolic syndrome in mice lacking a circadian clock","volume":"29","author":"Chaix","year":"2019","journal-title":"Cell Metab"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.9b03294","article-title":"Label-free detection of multiplexed metabolites at single-cell level via a SERS-microfluidic droplet platform","volume":"91","author":"Sun","year":"2019","journal-title":"Anal Chem"},{"key":"B175","doi-asserted-by":"publisher","first-page":"4582","DOI":"10.1038\/s41467-025-59878-w","article-title":"Dynamic single-cell metabolomics reveals cell-cell interaction between tumor cells and macrophages","volume":"16","author":"Zhang","year":"2025","journal-title":"Nat Commun"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-025-02407-8","article-title":"Spatially resolved multi-omics of human metabolic dysfunction-associated steatotic liver disease","volume":"57","author":"Li","year":"2025","journal-title":"Nat Genet"},{"key":"B177","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41467-024-55325-4","article-title":"Spatial transcriptomics of healthy and fibrotic human liver at single-cell resolution","volume":"16","author":"Watson","year":"2025","journal-title":"Nat Commun"},{"key":"B178","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.cmet.2016.09.018","article-title":"Metabolomics and metabolic diseases: Where do we stand","volume":"25","author":"Newgard","year":"2017","journal-title":"Cell Metab"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1899587\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T08:55:29Z","timestamp":1786956929000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1899587\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":178,"alternative-id":["10.3389\/fimmu.2026.1899587"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1899587","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"article-number":"1899587"}}